180 related articles for article (PubMed ID: 15688027)
1. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
Heidenblad M; Lindgren D; Veltman JA; Jonson T; Mahlamäki EH; Gorunova L; van Kessel AG; Schoenmakers EF; Höglund M
Oncogene; 2005 Mar; 24(10):1794-801. PubMed ID: 15688027
[TBL] [Abstract][Full Text] [Related]
2. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
[TBL] [Abstract][Full Text] [Related]
3. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
Suzuki A; Shibata T; Shimada Y; Murakami Y; Horii A; Shiratori K; Hirohashi S; Inazawa J; Imoto I
Cancer Sci; 2008 May; 99(5):986-94. PubMed ID: 18380791
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.
Heidenblad M; Schoenmakers EF; Jonson T; Gorunova L; Veltman JA; van Kessel AG; Höglund M
Cancer Res; 2004 May; 64(9):3052-9. PubMed ID: 15126341
[TBL] [Abstract][Full Text] [Related]
5. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
6. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.
Mahlamäki EH; Kauraniemi P; Monni O; Wolf M; Hautaniemi S; Kallioniemi A
Neoplasia; 2004; 6(5):432-9. PubMed ID: 15548351
[TBL] [Abstract][Full Text] [Related]
7. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
9. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of pancreatic cancer using microarray-based techniques.
Harada T; Chelala C; Crnogorac-Jurcevic T; Lemoine NR
Pancreatology; 2009; 9(1-2):13-24. PubMed ID: 19077451
[TBL] [Abstract][Full Text] [Related]
11. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.
Chen S; Auletta T; Dovirak O; Hutter C; Kuntz K; El-ftesi S; Kendall J; Han H; Von Hoff DD; Ashfaq R; Maitra A; Iacobuzio-Donahue CA; Hruban RH; Lucito R
Cancer Biol Ther; 2008 Nov; 7(11):1793-802. PubMed ID: 18836286
[TBL] [Abstract][Full Text] [Related]
12. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
[TBL] [Abstract][Full Text] [Related]
13. Copy-number variants in patients with a strong family history of pancreatic cancer.
Lucito R; Suresh S; Walter K; Pandey A; Lakshmi B; Krasnitz A; Sebat J; Wigler M; Klein AP; Brune K; Palmisano E; Maitra A; Goggins M; Hruban RH
Cancer Biol Ther; 2007 Oct; 6(10):1592-9. PubMed ID: 17912030
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.
Pollack JR; Sørlie T; Perou CM; Rees CA; Jeffrey SS; Lonning PE; Tibshirani R; Botstein D; Børresen-Dale AL; Brown PO
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12963-8. PubMed ID: 12297621
[TBL] [Abstract][Full Text] [Related]
15. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
[TBL] [Abstract][Full Text] [Related]
16. Identification of amplified and highly expressed genes in amplicons of the T-cell line huT78 detected by cDNA microarray CGH.
Meléndez B; Martínez-Delgado B; Cuadros M; Fernández V; Díaz-Uriarte R; Benítez J
Mol Cancer; 2005 Jan; 4(1):5. PubMed ID: 15656903
[TBL] [Abstract][Full Text] [Related]
17. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
Gorringe KL; Jacobs S; Thompson ER; Sridhar A; Qiu W; Choong DY; Campbell IG
Clin Cancer Res; 2007 Aug; 13(16):4731-9. PubMed ID: 17699850
[TBL] [Abstract][Full Text] [Related]
18. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
19. Targets of gene amplification and overexpression at 17q in gastric cancer.
Varis A; Wolf M; Monni O; Vakkari ML; Kokkola A; Moskaluk C; Frierson H; Powell SM; Knuutila S; Kallioniemi A; El-Rifai W
Cancer Res; 2002 May; 62(9):2625-9. PubMed ID: 11980659
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer.
Kwei KA; Bashyam MD; Kao J; Ratheesh R; Reddy EC; Kim YH; Montgomery K; Giacomini CP; Choi YL; Chatterjee S; Karikari CA; Salari K; Wang P; Hernandez-Boussard T; Swarnalata G; van de Rijn M; Maitra A; Pollack JR
PLoS Genet; 2008 May; 4(5):e1000081. PubMed ID: 18535672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
